广泛中和抗体-话题@MedSci

#广泛中和抗体#

7篇内容 | 846人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2206259, encodeId=3a992206259bc, content=<a href='/topic/show?id=62afe048720' target=_blank style='color:#2F92EE;'>#疫苗#</a> <a href='/topic/show?id=edbd88e6e7' target=_blank style='color:#2F92EE;'>#HIV#</a> <a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Cell：新研究发现一种实验性HIV疫苗可在人体中诱导广泛中和抗HIV抗体产生, objectType=article, longId=826765, objectId=3e52826e658e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240520/1716205444173_2185383.png, objectUrl=/article/show_article.do?id=3e52826e658e, replyNumber=0, likeNumber=0, createdTime=2024-05-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1511544, encodeId=15bc1511544b4, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Nature重磅：AAV递送CRISPR，体内改造B细胞，产生广泛中和抗体治疗艾滋病, objectType=article, longId=730169, objectId=9d23e3016970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d23e3016970, replyNumber=0, likeNumber=51, createdTime=2022-06-23, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d23e3016970, moduleTitle=Nature重磅：AAV递送CRISPR，体内改造B细胞，产生广泛中和抗体治疗艾滋病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d23e3016970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511543, encodeId=070415115430a, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Nat Med：1期临床试验表明广泛中和抗体PGT121可长期抑制患者体内的HIV感染, objectType=article, longId=219009, objectId=53b121900947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53b121900947, replyNumber=0, likeNumber=55, createdTime=2021-10-23, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53b121900947, moduleTitle=Nat Med：1期临床试验表明广泛中和抗体PGT121可长期抑制患者体内的HIV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53b121900947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511542, encodeId=c5a41511542e2, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=NEJM：广泛中和抗体用于HIV感染的预防, objectType=article, longId=208651, objectId=68a02086511a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68a02086511a, replyNumber=0, likeNumber=45, createdTime=2021-03-20, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68a02086511a, moduleTitle=NEJM：广泛中和抗体用于HIV感染的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68a02086511a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511541, encodeId=ca70151154163, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Science：如何产生引发广泛中和抗体反应的通用HIV疫苗？, objectType=article, longId=182422, objectId=f48718242220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f48718242220, replyNumber=0, likeNumber=35, createdTime=2019-11-07, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f48718242220, moduleTitle=Science：如何产生引发广泛中和抗体反应的通用HIV疫苗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f48718242220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511540, encodeId=0670151154003, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Nat Med：广泛中和抗体为HIV疫苗开发铺平道路, objectType=article, longId=80164, objectId=bdb78016436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdb78016436, replyNumber=0, likeNumber=0, createdTime=2016-10-17, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdb78016436, moduleTitle=Nat Med：广泛中和抗体为HIV疫苗开发铺平道路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bdb78016436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511539, encodeId=674f151153920, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=STM：HIV的“大智慧”——借助免疫耐受阻碍广泛中和抗体形成, objectType=article, longId=67738, objectId=e9626e738f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9626e738f4, replyNumber=0, likeNumber=49, createdTime=2016-05-09, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9626e738f4, moduleTitle=STM：HIV的“大智慧”——借助免疫耐受阻碍广泛中和抗体形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9626e738f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511538, encodeId=ccfd1511538bf, content=<a href='/topic/show?id=5ea34916196' target=_blank style='color:#2F92EE;'>#广泛中和抗体#</a>, objectTitle=Cell：揭秘HIV广泛中和抗体家族, objectType=article, longId=41101, objectId=73ce4110117, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ce4110117, replyNumber=0, likeNumber=40, createdTime=2014-10-12, rootId=0, userName=fmq_28614556, userId=fb4c10357319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ce4110117, moduleTitle=Cell：揭秘HIV广泛中和抗体家族, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ce4110117)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

广泛中和抗体

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#疫苗# #HIV# #广泛中和抗体#

2024-05-23发表于上海

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

Nature重磅：AAV递送CRISPR，体内改造B细胞，产生广泛中和抗体治疗艾滋病

2022-06-23

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

Nat Med：1期临床试验表明广泛中和抗体PGT121可长期抑制患者体内的HIV感染

2021-10-23

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

NEJM：广泛中和抗体用于HIV感染的预防

2021-03-20

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

Science：如何产生引发广泛中和抗体反应的通用HIV疫苗？

2019-11-07

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

Nat Med：广泛中和抗体为HIV疫苗开发铺平道路

2016-10-17

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

STM：HIV的“大智慧”——借助免疫耐受阻碍广泛中和抗体形成

2016-05-09

fmq_28614556 (审核中...)

前往app查看评论内容

#广泛中和抗体#

Cell：揭秘HIV广泛中和抗体家族

2014-10-12

科室
- - 订阅+
  - 更多科室
工具
服务